FSEA Q3 2024 Earnings Positive EPS of 001 Marks Operational Stability MPLX Q1 2026 Earnings EPS Misses Street Estimates as Margins Face Pressure ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment SCSC Q1 2026 Earnings Slight EPS Miss but Stock Gains on Solid Performance AVGO Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower NTGR Q1 2026 Earnings EPS Returns to Profitability with 268 Surprise DOCS Q1 2026 Earnings Mixed Results as EPS Misses Estimates but Stock Rises RCKY Q1 2026 Earnings EPS Misses Estimates by 3725 Amid Challenging Environment NCMI Q1 2026 Earnings EPS Misses Estimates Amid Cinema Advertising Headwinds NCS Multistage Holdings Inc NCSM Q1 2026 Earnings EPS Misses Estimates Significantly Revenue Data Unavailable MDGL Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid No Revenue Reported Neuraxis Inc NRXS Q1 2026 Earnings Narrower Loss Beats Estimates but Stock Slips on PreRevenue Concerns